Annette Brandt

发表

O. Witte, T. Grune, Anja Baumann, 2020, American journal of physiology. Gastrointestinal and liver physiology.

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance

Anja Baumann, I. Bergheim, C. Jin, 2021, Nutrients.

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging

E. Untersmayr, I. Bergheim, Annette Brandt, 2022, Nutrients.

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Anja Baumann, I. Bergheim, C. Jin, 2020, Nutrients.

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance

Anja Baumann, I. Bergheim, C. Jin, 2020, PloS one.

The recovery rate from severe acute malnutrition among under-five years of children remains low in sub-Saharan Africa. A systematic review and meta-analysis of observational studies

I. Bergheim, Anika Nier, Hanna Demelash Desyibelew, 2018, Nutrients.

Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.

Anja Baumann, I. Bergheim, C. Jin, 2020, Metabolism: clinical and experimental.

Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis.

Arndt Steube, I. Bergheim, A. Stallmach, 2020, Gastroenterology.

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function

J. Fernandez-Checa, Anja Baumann, I. Bergheim, 2018, Redox biology.

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease

M. Trauner, Anja Baumann, I. Bergheim, 2022, Journal of cellular and molecular medicine.

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.

Anja Baumann, I. Bergheim, M. L. Pisarello, 2022, Metabolism: clinical and experimental.

Microbiota profiling in aging-associated inflammation and liver degeneration.

O. Witte, C. Frahm, T. Grune, 2021, International journal of medical microbiology : IJMM.

Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.

Anja Baumann, I. Bergheim, C. Jin, 2017, The Journal of nutrition.

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

S. Mueller, I. Bergheim, Annette Brandt, 2021, Nutrients.

Fructose, a trigger of metabolic diseases?—a narrative review

Anja Baumann, I. Bergheim, Annette Brandt, 2022, Exploration of Digestive Diseases.

Effects of different standard and special diets on cognition and brain mitochondrial function in mice

I. Bergheim, T. Linn, G. Eckert, 2021, Nutritional neuroscience.

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'

O. Witte, K. Wagner, B. Wessner, 2022, Redox biology.

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects

I. Bergheim, Anika Nier, Tony Bruns, 2019, Molecular nutrition & food research.

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2021, Redox biology.

Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice

Anja Baumann, C. Jin, Annette Brandt, 2019, European Journal of Nutrition.

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2019, Scientific Reports.

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake

Anja Baumann, I. Bergheim, Anika Nier, 2019, Nutrients.

Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment

I. Bergheim, C. Jin, Annette Brandt, 2017, Nutrients.

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

J. Schattenberg, Anja Baumann, I. Bergheim, 2021, Scientific Reports.

Treatment with alpha‐galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function

I. Bergheim, C. Jin, Annette Brandt, 2017, Molecular nutrition & food research.

Gw9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Anja Baumann, I. Bergheim, Anika Nier, 2020, Journal of Hepatology.

I. Bergheim, Annette Brandt, Finn Jung, 2023, Exploration of Digestive Diseases.

Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2023, Cells.

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice

Anja Baumann, A. Camarinha-Silva, Annette Brandt, 2023, Biomolecules.

Antibiotics attenuate diet-induced non-alcoholic fatty liver disease without altering intestinal barrier dysfunction.

Anja Baumann, A. Camarinha-Silva, E. Halilbasic, 2023, The Journal of nutritional biochemistry.

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice

Anja Baumann, I. Bergheim, Annette Brandt, 2023, Redox biology.

Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression

T. Lammers, U. Rolle-Kampczyk, H. Marschall, 2024, JHEP reports : innovation in hepatology.